Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations-Reference-Cited by-同舟云学术

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

Published:2010-01 Issue:1 Volume:75 Page:123-132
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Anderson Ryan C.,Fox Christopher B.,Dutill Timothy S.,Shaverdian Narek,Evers Tara L.,Poshusta Garrett R.,Chesko James,Coler Rhea N.,Friede Martin,Reed Steven G.,Vedvick Thomas S.

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference46 articles.

1. Vaccine Adjuvants and Delivery Systems;Hem,2007

2. Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release

3. Influence of adjuvant formulation on the induced protection of mice immunized with total soluble antigen of Trichinella spiralis

4. Vaccine Adjuvants and Delivery Systems;O’Hagan,2007

5. Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Make it a combo;Science Translational Medicine;2024-07-31

2. Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine;Frontiers in Drug Delivery;2024-02-07

3. Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists;Heliyon;2023-07

4. Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial;Infectious Diseases and Therapy;2023-05-11

5. Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant;Tuberculosis;2023-03